Clinical Trial Update: Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of birinapant in advanced epithelial ovarian, fallopian tube, and peritoneal cancers was terminated; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer

Drugs mentioned

• Birinapant

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Epithelial Ovarian Cancer, Peritoneal Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2015-02-03